Decision on flu vaccine looms
Wall Street Journal, May 7, 2009
The Obama administration is weeks away from a critical decision on whether to trigger mass production of swine-flu vaccine, which could affect the bottom lines of big vaccine makers as well as public health. Besides determining whether a vaccine would be effective and safe, government officials and private laboratories will need to answer whether it makes sense to order hundreds of millions of doses and organize a mass vaccination campaign for a virus that, so far, isn't widespread and doesn't seem particularly lethal.
- How Top-Ranked MA Plans Earn Their Stars
- WellPoint Dominates Nearly Half of Markets, AMA Says
- CMS Offers Some ACOs $114M for 'Upfront' Costs
- How Hospitals Can Become 'Upstreamists'
- Ebola: Second TX Nurse Diagnosed After Improper Protective Gear Application
- Providers Ask HHS to Address EHR Interoperability Barriers
- The Drug Price Reform Debate
- 5 Digital Marketing Efforts Every Hospital Should Try
- 16 Medicare Advantage Plans Earn 5-Star Ratings
- Ebola: A Call for Designated Hospitals